Search results
Child mortality vs. share of children immunized against diphtheria, pertussis, and tetanus. Confidence in the effectiveness of vaccines vs. perception of importance. Costs of polio vaccines in low-income countries. Cumulative number of lives saved from vaccinations since 1974.
- Reported Cases of Measles
You have the permission to use, distribute, and reproduce...
- Reported Cases of Measles
Apr 1, 2020 · This statistical report, co-authored with Public Health England (PHE), reports childhood vaccination coverage statistics for England in 2020-21. Data relates to the routine vaccinations offered to all children up to the age of 5 years, derived from the Cover of Vaccination Evaluated Rapidly (COVER).
Annual data. NHS England currently publish the annual childhood vaccination statistics. This was previously produced by NHS Digital, which merged with NHS England in 2023. The annual publication reports childhood vaccination coverage statistics for England in the respective financial year.
- Advice
- Informed Consent
- Key Considerations
- Detailed Considerations
- Potential Health Benefits and Harms from Vaccination
- Vaccine Preventable Impacts on Education
- Vaccine Deployment and Wider Opportunities For Health and Education
- References
- Annex A
JCVI advises a non-urgent offer of two 10 mcg doses of the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) to children aged 5 to 11 years of age who are not in a clinical risk group. The 2 doses should be offered with an interval of at least 12 weeks between doses. The intention of this offer is to increase the immunity of vaccinated individuals agai...
In all instances, the offer of vaccination must be accompanied by appropriate information to enable children, and those with parental responsibility, to provide informed consent prior to vaccination. Teams responsible for the implementation and deployment of COVID-19 vaccination for persons aged 5 to 11 should be appropriately trained and confident...
Most children aged 5 to 11 have asymptomatic or mild disease following infection with SARS-CoV-2. Some may experience post-COVID-19 symptoms lasting longer than a few days. Children aged 5 to 11 years who are not in a COVID-19 clinical risk group are at extremely low risk of developing severe COVID-19 disease (references 1-3). Of those admitted to ...
In formulating the current advice for 5 to 11-year olds, JCVI considered evidence on 1. potential direct health benefits and harms 2. indirect educational impacts of vaccination 3. wider anticipated opportunity costs As vaccination against COVID-19 currently forms part of the UK pandemic response, a formal cost-benefit analysis incorporating these ...
In comparison to the rest of the population / older age groups, evidence indicates that children aged 5 to 11 are at the very lowest risk from COVID-19. Rates of hospitalisation, paediatric intensive care admission and death are lower in this age group than in all older age groups. In addition, the high level of prior infection in this age group of...
JCVI has considered evidence on the educational impact of COVID-19 on children aged 5 to 11 years, and how vaccination of children might mitigate these impacts. A major reason contributing towards a loss in education during the Omicron wave is absence from school due to self-isolation in the event of SARS-CoV2 infection amongst pupils. Because most...
Delivery of a vaccination programme that involves an injection to younger children is complex. It will typically require longer appointment times than for older children, child friendly settings and appropriately trained staff. Substantial time, care and resources will be necessary to deliver a positive programme. A poor experience of vaccination c...
A list of all data considered over time is available in the previous statement. 1. Ward and others, Risk factors for intensive care admission and death amongst children and young people admitted to hospital with COVID-19 and PIMS-TS in England during the first pandemic year 2. Smith and others, Deaths in children and young people in England followi...
Results
Table 3 shows the results for the two scenarios. Vaccine benefits are about 6 times greater for the more severe future wave compared to less severe. Note that most of these benefits can all be scaled to other scenarios of the parameters. For example, if the future wave was half the size, then the benefits would halve. If vaccine effectiveness was 90% instead of 70%, benefits improve by a ratio of 9/7. If the protection from past infection was 90% rather than 70%, then the benefits within thos...
Mikhalkov's Anna: 6–18 (1993) documents his daughter Anna as she grows from childhood to maturity. Mikhalkov's most famous production to date, Burnt by the Sun (1994), was steeped in the paranoid atmosphere of Joseph Stalin's Great Terror.
Jul 20, 2021 · A handful of vaccines have been tested in young people over the age of 12, including mRNA vaccines made by Moderna and Pfizer–BioNTech, and two Chinese vaccines made by Sinovac and Sinopharm ...
The following charts provide data on the share of people that have been vaccinated against by age group. This is provided as three metrics: the share that has received at least one dose; the share that has completed the initial protocol; and the share that is only partially vaccinated.
